Procter & Gamble (NYSE: PG) reported Q2 EPS of $1.88, $0.02 better than the analyst estimate of $1.86. Revenue for the quarter came in at $22.2 billion versus the consensus estimate of $22.34 billion.

GUIDANCE:

Procter & Gamble sees FY2026 EPS of $6.89-$7.09, versus the consensus of $6.96.

P&G maintained its guidance range for fiscal 2026 all-in sales growth to be in the range of one to five percent versus the prior year. The net impacts of foreign exchange rates and acquisitions and divestitures are expected to be a tailwind of approximately one percentage point to all-in sales growth. The Company also maintained its outlook for organic sales growth in the range of in-line to up four percent versus the prior year.

P&G adjusted its outlook for fiscal 2026 diluted net earnings per share growth to be in the range of one percent to six percent from prior guidance of three percent to nine percent versus fiscal 2025 diluted net EPS of $6.51, reflecting higher non-core restructuring charges in the year. P&G maintained its fiscal 2026 core earnings per share growth to be in the range of in-line to up four percent versus fiscal 2025 core EPS of $6.83. This outlook equates to a range of $6.83 to $7.09 per share, with a mid-point estimate of $6.96, or an increase of two percent.

For earnings history and earnings-related data on Procter & Gamble (PG) click here.